KLRG1 and cancer: Both 2B4 and KLRG1 have previously been linked to CD8 T cell exhaustion in chronic viral infection [45, 46] and targeting KLRG1 in combination with PD-1 blockade has been evaluated in an in vivo cancer model [47].